A TARGETED new drug for a rare and aggressive form of lung cancer will be fast-tracked to eligible patients within weeks, following a deal brokered by NHS England.
Patients in
Explore Ebooks
Categories
Explore Audiobooks
Categories
Explore Magazines
Categories
A TARGETED new drug for a rare and aggressive form of lung cancer will be fast-tracked to eligible patients within weeks, following a deal brokered by NHS England.
Patients in
You’re reading a preview, subscribe to read more.
Start your free 30 daysEbook
The street-wise patient's guide to surviving cancer: How to be an active, organised, informed and welcomed patient
byProfessor Karol SikoraEbook
Multidisciplinary Treatment of Colorectal Cancer: Staging – Treatment – Pathology – Palliation
byGunnar BaatrupEbook
Clinical Applications of Nuclear Medicine Targeted Therapy
byEmilio BombardieriEbook
Cancer Immunotherapy Meets Oncology: In Honor of Christoph Huber
byCedrik Michael BrittenEbook
Radiation Protection in Nuclear Medicine
bySören Mattsson